Bottom line
How much do BBH and FBIOX overlap?
36% of their top holdings overlap by weight. 9 securities appear in both funds' top 25, making up 56.7% of BBH's assets and 24.7% of FBIOX's. They share a meaningful core but differ in the rest of the portfolio.
FBIOX holds far more positions (215 vs 25), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings BBH and FBIOX have in common
| Holding | % of BBH | % of FBIOX | Overlap |
|---|---|---|---|
| Amgen Inc | 15.25% | 6.53% | 6.53% |
| Gilead Sciences Inc | 12.79% | 4.82% | 4.82% |
| Revolution Medicines Inc | 5.27% | 2.02% | 2.02% |
| Argenx SE | 4.97% | 2.25% | 2.25% |
| Natera Inc | 4.92% | 1.41% | 1.41% |
| Alnylam Pharmaceuticals Inc | 3.83% | 2.93% | 2.93% |
| Biogen Inc | 3.63% | 1.26% | 1.26% |
| Moderna Inc | 3.36% | 1.28% | 1.28% |
| Insmed Inc | 2.67% | 2.25% | 2.25% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in BBH
- Vertex Pharmaceuticals Inc — 9.10%
- Regeneron Pharmaceuticals Inc — 6.21%
- IQVIA Holdings Inc — 4.31%
- Illumina Inc — 3.17%
- United Therapeutics Corp — 2.83%
- BeOne Medicines Ltd — 2.81%
- Incyte Corp — 2.49%
- Neurocrine Biosciences Inc — 2.08%
- BioNTech SE — 1.94%
- Icon Plc — 1.90%
- Bio-Techne Corp — 1.54%
- Charles River Laboratories International Inc — 1.50%
- BioMarin Pharmaceutical Inc — 1.34%
- Qiagen Nv — 1.06%
- Tempus AI Inc — 0.98%
Only in FBIOX
- Krystal Biotech Inc — 10.58%
- Abbvie Inc — 9.22%
- Fidelity Revere Street Trust — 3.35%
- Praxis Precision Medicines Inc. — 2.47%
- Ascendis Pharma A/s — 2.04%
- Ucb Sa — 2.00%
- Jazz Pharmaceuticals Plc — 1.84%
- Scholar Rock Holding Corp — 1.55%
- Axsome Therapeutics Inc — 1.28%
- Protagonist Therapeutics Inc — 1.15%
- Roivant Sciences Ltd — 1.13%
- Cogent Biosciences Inc — 1.07%
- Tango Therapeutics Inc — 0.98%
- Celcuity Inc — 0.95%
- Madrigal Pharmaceuticals Inc — 0.93%
Asset mix
| Asset type | BBH | FBIOX |
|---|---|---|
| Stocks | 100.0% | 99.0% |
| Cash & short-term funds | 0.1% | 3.5% |
| Preferred stock | — | 0.9% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Country mix
| Country | BBH | FBIOX |
|---|---|---|
| US | 87.3% | 88.5% |
| NL | 6.0% | 2.9% |
| CH | 2.8% | 1.1% |
| DK | — | 2.6% |
| BE | — | 2.0% |
| IE | 1.9% | 2.0% |
| DE | 1.9% | — |
| BM | — | 1.1% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Check another pair
FAQ
How much do BBH and FBIOX overlap?
What stocks do BBH and FBIOX have in common?
Should I own both BBH and FBIOX?
Which holds more stocks, BBH or FBIOX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.